Quantcast

Latest tumor Stories

2014-03-24 12:30:19

Largest Study of Its Kind Shows Minimally Invasive Treatment May Slow Disease Progression in Liver While Maintaining Quality of Life SAN DIEGO, March 24, 2014 /PRNewswire-USNewswire/ -- A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain, according to research being presented at the Society of Interventional Radiology's 39th Annual...

2014-03-20 08:29:42

VANCOUVER, British Columbia and MENLO PARK, Calif., March 20, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided an update as of the quarter ended December 31, 2013 and a summary of progress toward the Company's goals for the year. DelMar also announced an investor conference call to take place today at 1 pm EDT. Details and log-in information will be posted on the website at www.delmarpharma.com in advance of the call....

Unnecessary Brain Scans Are A Headache For Everyone
2014-03-18 09:39:51

Brett Smith for redOrbit.com - Your Universe Online Many people with persistent headaches are worried about a cancerous growth on their brain and request that their doctor perform and imaging scan, but more often than not – it’s not a tumor. Because persistent headaches often have a more benign cause, US doctors perform around $1 billion worth of unnecessary and wasteful medical imaging tests, according to a new report from University of Michigan researchers that was published...

2014-03-18 08:33:01

SOUTH SAN FRANCISCO, Calif., March 18, 2014 /PRNewswire/ -- Calithera Biosciences, a clinical-stage biotechnology company focused on the development of novel cancer therapeutics, today announced the presentation of preclinical data for its lead anti-cancer therapeutic candidate, CB-839, at the Keystone Symposium on Tumor Metabolism being held in Whistler, Canada from March 16-21, 2014. CB-839 is a potent, selective, orally bioavailable glutaminase inhibitor that interferes with tumor...

2014-03-14 16:23:20

Data Showed Tumor Shrinkage in Both Injected and Metastasized Tumors THOUSAND OAKS, Calif., March 14, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced findings from a pre-specified retrospective analysis of patients with metastatic melanoma that showed talimogene laherparepvec reduced the size of injected tumors and also non-injected tumors that had metastasized to other parts of the body. The analysis recorded tumor-level responses from a pivotal Phase 3 study evaluating...

2014-03-11 08:29:44

Intravenous Delivery Is An Important Advancement in the Development of Toca 511, Creates Opportunity For Use In Additional Cancer Indications SAN DIEGO, March 11, 2014 /PRNewswire/ -- Tocagen Inc. today announced that the first patient has been dosed in its clinical trial investigating the intravenous administration of selective cancer therapy Toca 511 & Toca FC, in patients with recurrent high grade glioma (HGG) including glioblastoma multiforme (GBM, Grade 4 HGG), the most...

2014-03-09 23:00:57

The rapid growth of the Cancer Profiling Market is attributed to its promising application in personalized cancer therapy; and its extension in early diagnosis, disease prognosis, and research applications will further enhance its market growth - http://www.marketsandmarkets.com/Market-Reports/cancer-tumor-profiling-market-1250.html. (PRWEB) March 09, 2014 The "Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research),...

2014-03-06 13:13:25

Ludwig researchers show that infecting just 1 tumor with a virus could boost the systemic effectiveness of cancer immunotherapy A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherapy, an investigational intervention that employs viruses to destroy tumors. Published today in the journal Science Translational...

2014-03-04 13:06:04

It is not only genetics that predispose to bowel cancer; microbes living in the gut help drive the development of intestinal tumors, according to new research in mice published in the March issue of The Journal of Experimental Medicine. Bowel cancer, also called colorectal cancer, results from a series of genetic changes (mutations) that cause healthy cells to become progressively cancerous, first forming early tumors called polyps that can eventually become malignant. Although mutations...

2014-02-27 23:32:09

New treatment center is first of its kind in the nation. St. Louis, MO (PRWEB) February 27, 2014 This month, brain tumor patient Charlie North became the first patient at St. Louis Children’s Hospital to undergo proton beam therapy, a type of radiation that holds great promise for pediatric patients. In late November of last year, Julia and Jake North of Paris, Ill., had their lives turned upside down when they received news that Charlie, the oldest of their 6-year-old triplets, had a...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related